CN110876792A - Borneol plaster for relaxing muscles and tendons and activating collaterals - Google Patents
Borneol plaster for relaxing muscles and tendons and activating collaterals Download PDFInfo
- Publication number
- CN110876792A CN110876792A CN201810964662.9A CN201810964662A CN110876792A CN 110876792 A CN110876792 A CN 110876792A CN 201810964662 A CN201810964662 A CN 201810964662A CN 110876792 A CN110876792 A CN 110876792A
- Authority
- CN
- China
- Prior art keywords
- parts
- borneol
- prepared
- relaxing
- activating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 title claims abstract description 66
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 title claims abstract description 66
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 title claims abstract description 66
- 229940116229 borneol Drugs 0.000 title claims abstract description 64
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 title claims abstract description 63
- 239000011505 plaster Substances 0.000 title claims abstract description 9
- 210000002435 tendon Anatomy 0.000 title claims abstract description 9
- 230000003213 activating effect Effects 0.000 title claims abstract description 8
- 230000002040 relaxant effect Effects 0.000 title claims abstract description 8
- 210000003205 muscle Anatomy 0.000 title description 7
- 239000003814 drug Substances 0.000 claims abstract description 34
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 14
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 13
- 244000235603 Acacia catechu Species 0.000 claims abstract description 13
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 13
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 12
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 12
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 12
- 239000004863 Frankincense Substances 0.000 claims abstract description 12
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 11
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 11
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 11
- 241000208688 Eucommia Species 0.000 claims abstract description 11
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 11
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 11
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims abstract description 11
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 11
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 11
- 235000008397 ginger Nutrition 0.000 claims abstract description 11
- 229940041616 menthol Drugs 0.000 claims abstract description 11
- 241001254604 Angelica pubescens Species 0.000 claims abstract description 10
- 241000758794 Asarum Species 0.000 claims abstract description 10
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 10
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 10
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 10
- 241000725145 Homalomena Species 0.000 claims abstract description 10
- 241000212322 Levisticum officinale Species 0.000 claims abstract description 10
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 10
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 10
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 10
- 239000009136 dragon's blood Substances 0.000 claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 10
- 239000001645 levisticum officinale Substances 0.000 claims abstract description 10
- 239000009910 sargent gloryvine Substances 0.000 claims abstract description 10
- 241000489492 Arisaema Species 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 238000012545 processing Methods 0.000 claims abstract description 4
- 241000213006 Angelica dahurica Species 0.000 claims abstract 5
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 241000227129 Aconitum Species 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 241000331983 Arisaema consanguineum Species 0.000 claims description 2
- 235000011837 pasties Nutrition 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 35
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 230000036407 pain Effects 0.000 description 36
- 208000002193 Pain Diseases 0.000 description 35
- 208000024891 symptom Diseases 0.000 description 27
- 230000001737 promoting effect Effects 0.000 description 21
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 208000006820 Arthralgia Diseases 0.000 description 16
- 230000017531 blood circulation Effects 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 8
- 241000382455 Angelica sinensis Species 0.000 description 7
- 208000025747 Rheumatic disease Diseases 0.000 description 7
- 208000005392 Spasm Diseases 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 244000186071 dragons blood palm Species 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010005963 Bone formation increased Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 229920002367 Polyisobutene Polymers 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- FAMPSKZZVDUYOS-UHFFFAOYSA-N 2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 3
- 241000208173 Apiaceae Species 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 241001489978 Eupolyphaga Species 0.000 description 3
- 241000220485 Fabaceae Species 0.000 description 3
- DTGKSKDOIYIVQL-MRTMQBJTSA-N Isoborneol Natural products C1C[C@@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-MRTMQBJTSA-N 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 208000000112 Myalgia Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241000717739 Boswellia sacra Species 0.000 description 2
- 241000208229 Burseraceae Species 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010024453 Ligament sprain Diseases 0.000 description 2
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 2
- 241001057584 Myrrha Species 0.000 description 2
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- 244000107975 Strychnos nux-vomica Species 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000004417 patella Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 240000000031 Achyranthes bidentata Species 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 241000553739 Aconitum carmichaelii var. truppelianum Species 0.000 description 1
- 241000219317 Amaranthaceae Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 241000758795 Aristolochiaceae Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241001289295 Asarum sieboldii Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 241001098038 Callerya cinerea Species 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 241001148495 Cibotium barometz Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000159174 Commiphora Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000025962 Crush injury Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 229920001875 Ebonite Polymers 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 241000123866 Homalomena occulta Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 241000382840 Hyriopsis cumingii Species 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001113846 Loganiaceae Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001007959 Mucuna birdwoodiana Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 206010049514 Traumatic fracture Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- BXWQUXUDAGDUOS-UHFFFAOYSA-N gamma-humulene Natural products CC1=CCCC(C)(C)C=CC(=C)CCC1 BXWQUXUDAGDUOS-UHFFFAOYSA-N 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- QBNFBHXQESNSNP-UHFFFAOYSA-N humulene Natural products CC1=CC=CC(C)(C)CC=C(/C)CCC1 QBNFBHXQESNSNP-UHFFFAOYSA-N 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- -1 i.e. Chemical compound 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229940043266 rosin Drugs 0.000 description 1
- 238000010074 rubber mixing Methods 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Animal Husbandry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a borneol plaster for relaxing tendons and activating collaterals. The borneol tendon-relaxing and collateral-activating patch is prepared by preparing an extract from raw material medicines, uniformly mixing the extract with a framework material and auxiliary materials, processing and forming to prepare a patch, the raw material medicines comprise 15-20 parts of borneol, 2-7 parts of menthol, 1-7 parts of eucommia bark, 1-7 parts of dragon's blood, 1-7 parts of garden balsam stem, 1-7 parts of safflower, 1-7 parts of kusnezoff monkshood root, 1-7 parts of prepared frankincense, 1-7 parts of prepared myrrh, 1-7 parts of catechu, 1-7 parts of golden hair dog, 1-6 parts of pseudo-ginseng, 1-6 parts of obscured homalomena rhizome, 1-6 parts of dried ginger, 1-6 parts of Chinese angelica, 1-6 parts of asarum, 1-6 parts of sargentgloryvine stem, 1-5 parts of arisaema tuber, 1-5 parts of szechuan lovage rhizome, 1-5 parts of pubescent angelica root, 1-5 parts. The borneol tendon-relaxing and collateral-activating patch provided by the invention solves the technical problem that the traditional Chinese medicine formula in the prior art is relatively conservative in the use amount of borneol and cannot fully exert all effects of the borneol.
Description
Technical Field
The invention relates to the field of traditional Chinese medicine preparations, in particular to a borneol plaster for relaxing tendons and activating collaterals.
Background
Rheumatism and osteoarticular pain are very common pain syndromes of human beings, and besides accidental factors such as sprain and fall injury, the pathological responses of rheumatism and osteoarticular pain are mostly related to degenerative change of the spine, hyperosteogeny, nucleus pulposus degeneration, calcification, rupture, bulging and protrusion of intervertebral discs. Clinically, the symptoms of headache, dizziness, visual deterioration, limb movement obstruction, radioactive pain, numbness, cold and swelling, and even muscle atrophy causing disability. The clinical research of the traditional Chinese medicine considers that the chronic disease is caused by long-term invasion of wind, cold and dampness, chronic strain, or poor working habits and living habits, and the chronic disease is caused by the retrogressive change of organism tissues, the siltation of acid substances metabolized by microcirculation, the damage to channels and collaterals, the obstruction of qi and blood and the unsmooth blood circulation. The traditional Chinese medicine is commonly called arthralgia syndrome.
The treatment of the diseases has no special curative effect, and the functions of relieving and relieving pain are achieved by traction, operation, physical therapy, local closure, acupuncture and moxibustion and the like. Wherein, the patch is applied to the affected part for treatment, which is an effective treatment mode with convenient operation and wide application.
The patch in the prior art has a plurality of products adopting Chinese medicinal preparations, and borneol is taken as a medicinal material with the curative effects of inducing resuscitation, refreshing mind, clearing heat, removing toxicity, improving eyesight, removing nebula and the like, and the medicinal material is very in line with the requirement of product efficacy, so the borneol is widely used in the formulas of a plurality of products.
The natural borneol medicine source is in short supply and expensive, and most of the natural borneol medicine source is replaced by synthetic borneol. Although there is no definite theorem on the safety and toxicological experiments of natural borneol as compared to synthetic borneol, it is generally accepted that the median lethal dose of borneol is greater than that of isoborneol, i.e., borneol is less toxic than isoborneol. The stipulations of the pharmacopeia for synthesizing borneol are that the content of borneol is not less than 55%, and the borneol contains more isoborneol, so the dosage is more conservative.
Under the condition of low dosage, the borneol transdermal enhancer only can play a role in improving the bioavailability, the blood concentration of other medicines, the transdermal enhancer and the like, but cannot play the self-owned effects of inducing resuscitation, refreshing mind, clearing heat, relieving pain and the like.
However, since the camphor trees are newly found in Hunan in 1988, through years of artificial planting and large-scale production, the supply quantity of high-quality natural borneol is greatly increased and the price is also greatly reduced, so that the natural borneol is provided with a practical condition for using the natural borneol in a large amount.
Disclosure of Invention
In order to solve the technical problems that the traditional Chinese medicine formula in the prior art is conservative in the using amount of the borneol and cannot fully exert all the effects of the borneol, the invention provides the borneol tendon-relaxing and collateral-activating patch which is used in a large dose and fully exerts the effects of the borneol.
The borneol tendon-relaxing and collateral-activating patch comprises the following raw material medicines in parts by weight:
15-20 parts of borneol, 2-7 parts of menthol, 1-7 parts of eucommia bark, 1-7 parts of dragon's blood, 1-7 parts of garden balsam stem, 1-7 parts of safflower, 1-7 parts of kusnezoff monkshood root, 1-7 parts of prepared frankincense, 1-7 parts of prepared myrrh, 1-7 parts of catechu, 1-7 parts of golden hair dog, 1-6 parts of pseudo-ginseng, 1-6 parts of obscured homalomena rhizome, 1-6 parts of dried ginger, 1-6 parts of Chinese angelica, 1-6 parts of asarum, 1-6 parts of sargentgloryvine stem, 1-5 parts of arisaema tuber, 1-5 parts of szechuan lovage rhizome, 1-5 parts of doubleteeth pubescent angelica root, 1-5 parts.
In a preferred embodiment of the borneol tendon-relaxing and collateral-activating patch provided by the invention, the raw material medicines comprise the following components in parts by weight:
16-20 parts of borneol, 3-6 parts of menthol, 2-6 parts of eucommia bark, 2-6 parts of dragon's blood, 2-6 parts of garden balsam stem, 2-6 parts of safflower, 2-6 parts of kusnezoff monkshood root, 2-6 parts of prepared frankincense, 2-6 parts of prepared myrrh, 2-6 parts of catechu, 2-6 parts of golden hair dog, 2-5 parts of pseudo-ginseng, 2-5 parts of obscured homalomena rhizome, 2-5 parts of dried ginger, 2-5 parts of Chinese angelica, 2-5 parts of asarum, 2-5 parts of sargentgloryvine stem, 1-4 parts of arisaema tuber, 1-4 parts of szechuan lovage rhizome, 1-4 parts of doubleteeth pubescent angelica root, 1-4 parts.
In a preferred embodiment of the borneol tendon-relaxing and collateral-activating patch provided by the invention, the raw material medicines comprise the following components in parts by weight:
17-19 parts of borneol, 4-5 parts of menthol, 3-5 parts of eucommia bark, 3-5 parts of dragon's blood, 3-5 parts of garden balsam stem, 3-5 parts of safflower, 3-5 parts of kusnezoff monkshood root, 3-5 parts of prepared frankincense, 3-5 parts of prepared myrrh, 3-5 parts of catechu, 3-5 parts of golden retriever's dog, 3-4 parts of pseudo-ginseng, 3-4 parts of homalomena rhizoma, 3-4 parts of dried ginger, 3-4 parts of Chinese angelica, 3-4 parts of asarum, 3-4 parts of sargentgloryvine stem, 2-3 parts of arisaema tuber, 2-3 parts of szechuan lovage rhizome, 2-3 parts of doubleteeth pubescent angelica root, 2-3.
In a preferred embodiment of the borneol tendon-relaxing and collateral-activating patch provided by the invention, the raw material medicines comprise the following components in parts by weight:
18 parts of borneol, 4.6 parts of menthol, 4 parts of eucommia bark, 4 parts of dragon's blood, 4 parts of garden balsam stem, 4 parts of safflower, 4 parts of kusnezoff monkshood root, 4 parts of prepared frankincense, 4 parts of prepared myrrh, 4 parts of catechu, 4 parts of golden hair dog, 3.5 parts of pseudo-ginseng, 3.5 parts of obscured homalomena rhizome, 3.5 parts of dried ginger, 3.5 parts of Chinese angelica, 3.5 parts of asarum, 3.5 parts of sargentgloryvine stem, 2.8 parts of arisaema consanguineum, 2.8 parts of szechuan lovage rhizome, 2.8 parts of doubleteeth pubescent angelica root, 2.
In a preferred embodiment of the borneol tendon-relaxing and collateral-activating patch provided by the invention, the borneol is natural borneol.
The natural borneol contains diterpene components such as dextro-borneol humulene, β -elemene, caryophyllene and the like and triterpenoid components such as oleanolic acid, hordenic acid, asiatic acid, borneol bergol ketone and the like, has good anti-inflammatory, antibacterial, analgesic and hypnotic effects, and has the effect of promoting division and growth of glial cells.
Menthol is the main volatile oil extract of peppermint. Has the efficacy of dispelling wind and heat, and has the following effects: diminishing inflammation, relieving pain, invigorating stomach, dispelling pathogenic wind, and relieving itching. Can be used for treating affection of exogenous wind-heat, and can be used as adjuvant medicine for relieving exterior syndrome by diaphoresis; help other exterior-releasing drugs to promote eruption; can be used for treating summer-heat manifested by dizziness, fever, thirst, and scanty and brownish urine.
The Eucommiae cortex is dry bark of eucommia ulmoides Oliver belonging to genus eucommia of family Eucommiaceae, and contains aucubin and a hard rubber, and the bark contains resin and tannin. Has the effects of nourishing liver and kidney, strengthening bones and muscles, preventing miscarriage and the like, and has the following functions: lowering blood pressure, and tranquilizing. It is mainly used for treating lumbago, especially lumbago due to kidney deficiency; for fetal movement, vaginal bleeding, abdominal pain due to kidney deficiency; for hypertension, it is suitable for kidney deficiency type.
Sanguis Draxonis is red resin secreted by mature fruit of daemonorops draco of Palmae. Has effects in promoting blood circulation, relieving pain, removing blood stasis, and promoting tissue regeneration; stopping bleeding and promoting granulation for external use. It is mainly used for treating traumatic injury with pain in heart and abdomen or hemorrhage, and is often combined with Olibanum, Myrrha, Catechu, Borneolum, etc. to have effects of promoting blood circulation for removing blood stasis, and relieving swelling and pain.
The garden balsam stem has the efficacies of dispelling wind and eliminating dampness, and detoxifying and relieving pain, and has the functions of treating rheumatic arthralgia and treating pyocutaneous disease and pyogenic infections by external use. It is used in combination with caulis Spatholobi to tonify liver and kidney, activate blood and alleviate pain.
Carthami flos is dried flower of Compositae annual or biennial herb Carthami flos. Has effects of removing blood stasis, promoting blood circulation, and dredging channels, and has effects of exciting uterus, lowering blood pressure, and dilating blood vessel. Can be used for treating dysmenorrhea due to blood stasis, amenorrhea, coronary heart disease, angina pectoris, traumatic injury, and regulating qi and blood.
The kusnezoff monkshood root contains aconitine, Chinese monkshood, azepin and the like, and the kusnezoff monkshood root tuber is toxic and can expel wind and remove dampness, warm meridians and relieve pain when being used as a medicine. Can be used for treating arthralgia due to wind-cold-dampness, arthralgia, psychroalgia of heart and abdomen, cold hernia pain, anesthesia and pain relieving, and has strong analgesic effect.
The Olibanum is dried resin of small arbor of Burseraceae plant or Boswellia carterii Bowda Makino and Boswellia serrata L. Has effects of promoting blood circulation, relieving pain, relaxing muscles and tendons, and relieving pain and inflammation. It is commonly used as an analgesic in traumatology and surgery, and often combined with Mo Yao. Used for treating pain due to blood stasis; used for muscular spasm; the external application promotes wound healing.
The Myrrha is dried resin of Commiphora myrrha (Commiphora myrrha) of Burseraceae or Commiphora deltoidea. Has effects of promoting blood circulation, removing blood stasis, relieving pain, astringing, relieving inflammation, promoting blood circulation, relieving pain, and promoting granulation. Has different degrees of inhibition effects on various dermatophytes. It is often combined with Ru Xiang.
Catechu is dried extract obtained by concentrating decoction of core pieces of branches and stems of Catechu tree of deciduous tree of Leguminosae. Has astringent, antiinflammatory, hemostatic, enterokinesia inhibiting, antiviral, and antifungal effects. Can be used for treating rhinitis and sinusitis; can be used for treating stomatitis and pharyngolaryngitis; can be used for treating epistaxis and hemorrhage due to hemorrhoid; can be used for treating traumatic hemorrhage.
The Cibotium barometz is dry rhizome of rhizoma Cibotii of perennial herb of Hyriopsis cumingii. Has the effects of strengthening tendons and bones and dispelling wind-damp, and is suitable for patients with rheumatic arthralgia and deficiency of liver and kidney. It is suitable for the weak elderly with cold-dampness, knee pain, lumbago, especially the stiff and painful waist and back, and difficulty in flexion and extension.
Notoginseng radix is the dried root of Panax notoginseng (Burk.) F.H.Chen of Araliaceae. Has hemostatic, blood stasis dispelling, repercussive, and analgesic effects, and is effective for stopping bleeding, relieving inflammation, and increasing coronary blood flow. It is a key herb for stopping bleeding and resolving stasis, and is used for treating traumatic injury and internal injury or traumatic hemorrhage; treating hematemesis and gastrorrhagia; it can be used for treating hemorrhage due to hematopathy.
Rhizoma homalomenae is dried rhizome of Homalomena occulta of Araceae. The medicine has pungent and warm properties, pungent and pungent flavor, can tonify warmly, has the functions of expelling wind-damp, strengthening muscles and bones, relieving pain and eliminating swelling, has good pain and wind-damp expelling capability, and is a common medicine for treating anemofrigid-damp arthralgia. It is especially suitable for old people with soreness and weakness of bones and muscles. Can be used for treating rheumatic arthralgia, soreness of waist and knees, spasm and numbness.
The Zingiberis rhizoma is rhizome of Zingiber officinale Roscoe of Zingiberaceae. Has digestion promoting effect; exciting the central respiratory and motor system; has effects in promoting blood circulation, increasing blood pressure, and promoting perspiration.
The Angelica sinensis Diels is dried root of Angelica sinensis Diels of Umbelliferae. Has effects in tonifying blood, promoting blood circulation, moistening intestine, regulating menstruation, tranquilizing mind, relieving pain, promoting urination, and inhibiting bacteria. For blood-nourishing and blood-circulation-promoting herbs, it is usually used for blood syndrome, deficiency syndrome, exterior syndrome and abscess.
The herba asari is dry whole plant of perennial herb of Aristolochiaceae, herba asari Forbesii and Asarum sieboldii with root. Has the effects of dispelling cold, eliminating phlegm and relieving pain, and has the following functions: antipyretic, antibacterial, and analgesic effects. Can be used for treating cough due to phlegm and fluid retention, and treating wind cold common cold, headache and arthralgia caused by rheumatism or influenza.
Caulis Sargentodoxae is dry rattan of Leguminosae vine, such as Mucuna birdwoodiana and Millettia dielsiana. Has the effects of promoting blood circulation, dredging collaterals, warming waist and knee, and has the functions of nourishing blood, enriching blood, promoting blood circulation, dispelling pathogenic wind, dredging collaterals and relieving pain. Can be used for treating rheumatalgia, senile hand and foot impotence, paralysis, vertigo, menoxenia, and aplastic anemia.
The rhizoma arisaematis is dry tuber of rhizoma arisaematis, northeast rhizoma arisaematis, or rhizoma arisaematis heterophylla, which belongs to various rhizoma arisaematis without outer skin. Has the effects of dispelling wind, relieving spasm, eliminating dampness and eliminating phlegm, and is a common medicine for dispelling wind-phlegm and relieving spasm and epilepsy
Rhizoma Ligustici Chuanxiong is rhizome of herbal plant rhizoma Ligustici Chuanxiong of Umbelliferae. Has effects of promoting blood circulation, activating qi-flowing, dispelling pathogenic wind and relieving pain, and can be used for treating pain due to blood stasis and qi stagnation; can be used for treating headache and rheumatic arthralgia.
Radix Angelicae Pubescentis is dried root of Angelica gigas nakai of Angelica of Umbelliferae. Has effects of dispelling pathogenic wind and removing dampness, dredging channels and collaterals, relieving pain, tranquilizing mind, and contracting blood vessel. Can be used for treating rheumatism, especially neck and back muscle rheumatism and lower body joint rheumatism, soreness of waist and back or hip and knee, and numbness of feet; can be used for treating headache due to damp invasion of cold and wind cold.
The Eupolyphaga Seu Steleophaga is dry body of Eupolyphaga Seu Steleophaga or female Eupolyphaga of Corydaceae. Has effects of removing blood stasis, and resolving stagnation, and can be used for treating amenorrhea due to blood stasis, abdominal pain due to agglomeration, and pain due to traumatic blood stasis.
Semen Strychni is mature dry seed of Yunnan nux vomica of climbing woody vine of Loganiaceae. Has effects of exciting central nervous system, promoting blood circulation and respiratory movement, and slightly increasing pressure. Can be used for treating traumatic fracture, injury, sprain, contusion, and crush injury; it can be used for treating throat pain.
The Glycyrrhrizae radix is dried root and rhizome of Leguminosae perennial herb such as Glycyrrhrizae radix and Glycyrrhiza glabra L. Has effects of invigorating spleen and qi, clearing away heat and toxic materials, moistening lung, relieving cough, removing toxic substances, and adrenocorticoid-like hormone, relieving spasm, inhibiting gastric acid secretion, and eliminating phlegm. It is mainly used as the essential herb for the harmonization of the demulcent, and it is usually used in cases where the property of herbs should be moderated and qi should be harmonized.
Achyranthis radix is the dried root of Achyranthis radix of Amaranthaceae family. Has the effects of dissipating blood stasis, relieving pain, promoting blood circulation, stimulating the menstrual flow, and tonifying liver and kidney, and has the following effects: relieving pain, promoting urination, relieving spasm, and lowering blood pressure. For treating pain in waist and lower extremities, no matter the reason of pain in waist and lower extremities belongs to kidney deficiency, rheumatism or traumatic injury, achyranthes bidentata is a commonly used medicine; treating stranguria; it can be used for treating rheumatalgia, hypertension, and gingival swelling and pain.
Ramulus Uncariae cum uncis is dry stem branch with hook of ramulus Uncariae cum uncis and ramulus Uncariae cum uncis of Rubiaceae. Has effects of suppressing hyperactive liver and relieving spasm, and has effects of lowering blood pressure and tranquilizing mind. It is indicated for convulsions due to heat syndrome.
The invention provides a production process of a borneol tendon-relaxing collateral-activating plaster, which specifically comprises the following steps:
the method comprises the following steps: pulverizing the raw materials into coarse powder;
step two: soaking the coarse powder in high-concentration ethanol for multiple days;
step three: percolating, and collecting percolate;
step four: recovering ethanol, and concentrating the percolate to obtain pasty extract;
step five: mixing the extract with skeleton material and adjuvants;
step six: processing and molding to obtain the patch.
The borneol tendon-relaxing and collateral-activating patch provided by the invention uses natural borneol as a main active ingredient, utilizes a high-concentration preparation with the concentration close to 20% and is matched with other medicinal materials, so that the treatment effect of the natural borneol is effectively and fully exerted, and the borneol tendon-relaxing and collateral-activating patch has exact curative effects on rheumatic diseases and joint variability diseases.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and the described embodiments are only a part of the embodiments of the present invention, but not all of the embodiments.
The borneol plaster for relaxing tendons and activating collaterals is prepared by the following steps:
the method comprises the following steps: preparing materials including 810g of borneol, 200g of menthol, 180g of eucommia bark, 180g of dragon's blood, 180g of garden balsam stem, 180g of safflower, 180g of kusnezoff monkshood root, 180g of prepared frankincense, 180g of prepared myrrh, 180g of catechu, 180g of golden retriever, 150g of pseudo-ginseng, 150g of obscured homalomena rhizome, 150g of dried ginger, 150g of Chinese angelica, 150g of asarum, 150g of sargentgloryvine stem, 120g of rhizoma arisaematis, 120g of szechuan lovage rhizome, 120g of pubescent angelica root, 120g of ground beeltle, 100g of nux vomica, 100g of liquorice;
step two: cleaning the above materials, oven drying, and respectively grinding into powder;
step three: pouring the powder into 30L of 75% ethanol, and soaking for 7 days;
step four: percolating at speed of 5 ml/min, and collecting percolate 20000 ml;
step five: recovering ethanol, and concentrating to obtain thick paste with the relative density of 1.33-1.35;
step six: cutting polyisobutylene into small pieces, breaking the polyisobutylene in a rubber mixing mill, discharging the polyisobutylene from a screen, and then placing the polyisobutylene on a metal net rack for more than 48 hours to eliminate static electricity;
step seven: soaking the broken rubber in gasoline for 48 hours to form latex, sequentially adding rosin, zinc oxide, vaseline and lanolin, and continuously mixing for 3 hours;
step eight: after the base materials are mixed uniformly, adding the thick paste, and continuously mixing for 3 hours;
step nine: filtering the mixed material in a filter to remove impurities, and standing for 48 hours again;
step ten: then carrying out the conventional processing steps of gluing, drying, rolling, cutting and slicing to obtain the finished product of the sheet patch.
When in use, the patch is directly applied to the affected part until the drug effect is exerted.
The borneol tendon-relaxing and collateral-activating patch is prepared from classical ancient prescriptions, is an external medicine and has extremely low risk in the aspect of medication safety, so that clinical tests are directly carried out.
In a rehabilitation hospital, patients who have been diagnosed with symptoms such as joint pain, arthralgia and myalgia and who have been diagnosed with rheumatic diseases and joint variability diseases, and patients who have been diagnosed with the symptoms, are tested for clinical use. Wherein, 12 patients with arthralgia, arthralgia and myalgia and hyperosteogeny are respectively treated.
The patch is applied 1 day, 7 patches are 1 course of treatment, and 3 courses of treatment are adopted, and the next course of treatment is not carried out when symptoms are obviously improved. After stopping taking the medicine, observing for 7 days, taking the final effect as a judgment standard, and obtaining the following specific results:
1. 12 patients with arthralgia, 7 patients with no symptom, 4 patients with significant symptom reduction, 1 patient with slight symptom reduction and 0 patient with complete ineffectiveness;
2. 12 patients with arthralgia and myalgia, 5 patients with no symptom, 5 patients with significant symptom reduction, 2 patients with slight symptom reduction and 0 patient with complete ineffectiveness.
3. The patients with the hyperosteogeny comprise 12 patients, 6 patients with no symptom, 5 patients with significant symptom reduction, 1 patient with slight symptom reduction and 0 patient with complete ineffectiveness.
The total of 36 patients with the symptom disappeared and obviously improved is 32, and the effective rate is 89%. Wherein the patients with symptom disappearance are 18 patients, and the cure rate is 50 percent. Obviously, the borneol tendon relaxing and collateral activating plaster has exact curative effects on rheumatic diseases and joint variability diseases.
The symptoms of fever and pruritus of the affected part appear in 18 cured people. 6 of 14 people with significantly reduced symptoms also developed symptoms of fever at the affected area. A total of 4 patients with significantly and slightly reduced symptoms had transient pain at the superficial part of the lesion.
The therapeutic effect of the present invention is illustrated below by several clinical cases:
case 1:
liu Yi, male, 63 years old, diagnosed by the above mentioned rehabilitation hospital for patella strain, after 2 courses of treatment the patient showed the symptom disappeared. After the medicine is stopped for one week, the patient shows no relapse, can normally squat down and has no pain when going up and down stairs. The color Doppler ultrasound diagnosis is carried out on the patient in the hospital, the patella softening condition is confirmed to be relieved, and the treatment is effective.
When a patient is in 57 years old, the scapulohumeral periarthritis is diagnosed, and the patient shows that the symptoms disappear after 3 treatment courses. The patient who stops taking the medicine for one week shows no recurrence, no pain on the shoulder, and normal actions such as abduction, ascent, internal rotation and external rotation. The X-ray diagnosis is carried out on the patient, the normal condition of the soft tissues of the shoulder is confirmed, and the treatment is effective.
Luo Bi, male, 45 years old, was diagnosed with meniscal cartilage damage in the knee joint, and patients after 3 treatment courses showed effective relief of symptoms. After one week of withdrawal, the patient showed that the symptoms had not disappeared but continued to improve. The patient is examined and diagnosed, and the symptom is confirmed to be obviously improved compared with the symptom before treatment, so that the treatment is effective.
Li Yi, female, 65 years old, diagnosed with lumbar hyperosteogeny, and after 3 courses of treatment, the patient showed the disappearance of symptoms. The patient who stops taking the medicine for one week shows no recurrence, and the waist can normally move without pain. The patient is diagnosed by color ultrasound, the hyperplasia is confirmed to be reduced, and the treatment is effective.
Tang Dynasty, male, age 68, diagnosed with degenerative arthritis, showed disappearance of symptoms after 3 courses of treatment. The patient does not relapse after stopping taking the medicine for one week, the knee joint can normally move, and the patient does not have pain when moving again after no action for a long time. X-ray diagnosis is carried out on the patient to confirm that the knee joint condition is normal and the treatment is effective.
The above description is only an embodiment of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes, which are made by the present specification, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.
Claims (6)
1. The borneol plaster for relaxing tendons and activating collaterals is prepared by preparing an extract from raw material medicines, uniformly mixing the extract with a framework material and auxiliary materials, and processing and forming the mixture to prepare the plaster, and is characterized in that the raw material medicines comprise the following components in parts by weight:
15-20 parts of borneol, 2-7 parts of menthol, 1-7 parts of eucommia bark, 1-7 parts of dragon's blood, 1-7 parts of garden balsam stem, 1-7 parts of safflower, 1-7 parts of kusnezoff monkshood root, 1-7 parts of prepared frankincense, 1-7 parts of prepared myrrh, 1-7 parts of catechu, 1-7 parts of golden hair dog, 1-6 parts of pseudo-ginseng, 1-6 parts of obscured homalomena rhizome, 1-6 parts of dried ginger, 1-6 parts of Chinese angelica, 1-6 parts of asarum, 1-6 parts of sargentgloryvine stem, 1-5 parts of arisaema tuber, 1-5 parts of szechuan lovage rhizome, 1-5 parts of doubleteeth pubescent angelica root, 1-5 parts.
2. The borneol tendon-relaxing and collateral-activating patch as claimed in claim 1, wherein the raw material medicines are composed of the following components in parts by weight:
16-20 parts of borneol, 3-6 parts of menthol, 2-6 parts of eucommia bark, 2-6 parts of dragon's blood, 2-6 parts of garden balsam stem, 2-6 parts of safflower, 2-6 parts of kusnezoff monkshood root, 2-6 parts of prepared frankincense, 2-6 parts of prepared myrrh, 2-6 parts of catechu, 2-6 parts of golden hair dog, 2-5 parts of pseudo-ginseng, 2-5 parts of obscured homalomena rhizome, 2-5 parts of dried ginger, 2-5 parts of Chinese angelica, 2-5 parts of asarum, 2-5 parts of sargentgloryvine stem, 1-4 parts of arisaema tuber, 1-4 parts of szechuan lovage rhizome, 1-4 parts of doubleteeth pubescent angelica root, 1-4 parts.
3. The borneol tendon-relaxing and collateral-activating patch as claimed in claim 2, wherein the raw material medicines are composed of the following components in parts by weight:
17-19 parts of borneol, 4-5 parts of menthol, 3-5 parts of eucommia bark, 3-5 parts of dragon's blood, 3-5 parts of garden balsam stem, 3-5 parts of safflower, 3-5 parts of kusnezoff monkshood root, 3-5 parts of prepared frankincense, 3-5 parts of prepared myrrh, 3-5 parts of catechu, 3-5 parts of golden retriever's dog, 3-4 parts of pseudo-ginseng, 3-4 parts of homalomena rhizoma, 3-4 parts of dried ginger, 3-4 parts of Chinese angelica, 3-4 parts of asarum, 3-4 parts of sargentgloryvine stem, 2-3 parts of arisaema tuber, 2-3 parts of szechuan lovage rhizome, 2-3 parts of doubleteeth pubescent angelica root, 2-3.
4. The borneol tendon-relaxing and collateral-activating patch as claimed in claim 3, wherein the raw material medicines are composed of the following components in parts by weight:
18 parts of borneol, 4.6 parts of menthol, 4 parts of eucommia bark, 4 parts of dragon's blood, 4 parts of garden balsam stem, 4 parts of safflower, 4 parts of kusnezoff monkshood root, 4 parts of prepared frankincense, 4 parts of prepared myrrh, 4 parts of catechu, 4 parts of golden hair dog, 3.5 parts of pseudo-ginseng, 3.5 parts of obscured homalomena rhizome, 3.5 parts of dried ginger, 3.5 parts of Chinese angelica, 3.5 parts of asarum, 3.5 parts of sargentgloryvine stem, 2.8 parts of arisaema consanguineum, 2.8 parts of szechuan lovage rhizome, 2.8 parts of doubleteeth pubescent angelica root, 2.
5. The borneol tendon-relaxing and collateral-activating patch as claimed in any one of claims 1 to 4, wherein: the borneol is natural borneol.
6. The borneol tendon-relaxing and collateral-activating patch as claimed in any one of claims 1 to 4, wherein: the extract prepared from the raw material medicines specifically comprises the following steps:
the method comprises the following steps: pulverizing the raw materials into coarse powder;
step two: soaking the coarse powder in high-concentration ethanol for multiple days;
step three: percolating, and collecting percolate;
step four: recovering ethanol, and concentrating the percolate to obtain pasty extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810964662.9A CN110876792A (en) | 2018-08-23 | 2018-08-23 | Borneol plaster for relaxing muscles and tendons and activating collaterals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810964662.9A CN110876792A (en) | 2018-08-23 | 2018-08-23 | Borneol plaster for relaxing muscles and tendons and activating collaterals |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110876792A true CN110876792A (en) | 2020-03-13 |
Family
ID=69726963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810964662.9A Pending CN110876792A (en) | 2018-08-23 | 2018-08-23 | Borneol plaster for relaxing muscles and tendons and activating collaterals |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110876792A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634310A (en) * | 2004-09-23 | 2005-07-06 | 窦传磊 | Plaster for treating rheumatoid, fracture, sprain and arthritis and preparation method thereof |
CN1663577A (en) * | 2004-03-03 | 2005-09-07 | 王红旗 | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis |
CN101890150A (en) * | 2010-03-20 | 2010-11-24 | 李志刚 | Novel and special Likexiao |
CN106540022A (en) * | 2015-09-23 | 2017-03-29 | 张生利 | A kind of medicine for treating rheumatic osteopathia |
CN106692934A (en) * | 2017-01-18 | 2017-05-24 | 韩爱民 | Pain-relieving black ointment and preparation method thereof |
CN107648415A (en) * | 2017-11-08 | 2018-02-02 | 黄康 | A kind of ointment that relieves the pain with function promoting blood circulation and removing blood stasis |
CN108144033A (en) * | 2018-02-12 | 2018-06-12 | 潘胡林 | A kind of Application of Black Plaster for treating cervical vertebra pain in waist and lower extremities and apoplexy sequelae |
-
2018
- 2018-08-23 CN CN201810964662.9A patent/CN110876792A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1663577A (en) * | 2004-03-03 | 2005-09-07 | 王红旗 | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis |
CN1634310A (en) * | 2004-09-23 | 2005-07-06 | 窦传磊 | Plaster for treating rheumatoid, fracture, sprain and arthritis and preparation method thereof |
CN101890150A (en) * | 2010-03-20 | 2010-11-24 | 李志刚 | Novel and special Likexiao |
CN106540022A (en) * | 2015-09-23 | 2017-03-29 | 张生利 | A kind of medicine for treating rheumatic osteopathia |
CN106692934A (en) * | 2017-01-18 | 2017-05-24 | 韩爱民 | Pain-relieving black ointment and preparation method thereof |
CN107648415A (en) * | 2017-11-08 | 2018-02-02 | 黄康 | A kind of ointment that relieves the pain with function promoting blood circulation and removing blood stasis |
CN108144033A (en) * | 2018-02-12 | 2018-06-12 | 潘胡林 | A kind of Application of Black Plaster for treating cervical vertebra pain in waist and lower extremities and apoplexy sequelae |
Non-Patent Citations (1)
Title |
---|
傅京亮: "《香学三百问》", 31 July 2014, 三晋出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6027728A (en) | Herbal skin regeneration composition and method | |
CN103520654B (en) | A kind of Chinese medicine composition being used for the treatment of knee osteoarthritis and preparation method thereof | |
CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
CN102973862B (en) | Chinese medicine preparation for treating skin itch | |
CN104524530B (en) | A kind of Chinese medicine composition and its application in the medicine for preparing treatment arthralgia and myalgia | |
CN1322885C (en) | Plaster medicine composition with multiple purpose for treating affection pain due to dampness | |
CN102008576B (en) | A kind of external Chinese medicine for treating sprain and preparation method thereof | |
CN103393999A (en) | Anti-inflammatory resolutive liquid medicine for promoting blood circulation to arrest pain | |
CN102579936A (en) | Shennong medicinal liquor and preparation method thereof | |
CN108853390A (en) | The Chinese materia medica preparation and preparation method thereof for treating gonitis | |
CN115227802A (en) | Growth-promoting acupoint plaster formula and preparation method thereof | |
CN112957441A (en) | A topical medicinal film for dispelling pathogenic wind, removing dampness, warming and dredging channels and collaterals, promoting blood circulation and relieving pain, and its preparation method | |
CN101934016B (en) | External medicament for treating arthritis | |
CN110876792A (en) | Borneol plaster for relaxing muscles and tendons and activating collaterals | |
CN104873723B (en) | Cinnamon oil-containing medicine for treating burns and scalds | |
CN116889602B (en) | A topical Chinese medicinal composition for treating synovitis and tenosynovitis, and its preparation method | |
CN105343298B (en) | Navel patch for treating chronic constipation and preparation method thereof | |
CN110856731A (en) | Traditional Chinese medicine external navel treatment ointment formula and preparation method thereof | |
CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
CN102028872B (en) | Oral Chinese medicine for treating acute lumbar sprain and preparation method thereof | |
CN105998516A (en) | Preparation method for traditional Chinese medicine for treating congealing cold and blood stasis painful heel and composition of traditional Chinese medicine | |
CN106074813A (en) | A kind of Chinese medicine fumigation and washing soaking agent treating talalgia and preparation method thereof | |
CN105560537A (en) | A kind of pharmaceutical composition for treating osteoarthropathy and preparation method thereof | |
CN102949534B (en) | Traditional Chinese medicine for treating cervical spondylosis and preparation method thereof | |
CN104940524A (en) | Medicine for treating leucoderma and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200313 |
|
RJ01 | Rejection of invention patent application after publication |